AGP Picks
View all

Tech Times of New York
Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 21, 2026

Toro Corp. Announces Record Date for the Proposed Spin-off of its LPG Carrier Business
Sep. 21, 2026

Toro Corp. Announces Record Date for the Proposed Spin-off of its LPG Carrier Business

Indeterminate GlobeNewswire
Valour, eine Tochtergesellschaft von DeFi Technologies, führt mit „Valour Funds SPC“ einen neuen Geschäftsbereich ein und präsentiert ihren ersten Hedgefonds, den „Smart Crypto Fund SP“, der auf der proprietären KI-Strategie von Neuronomics…
Sep. 21, 2026

Valour, eine Tochtergesellschaft von DeFi Technologies, führt mit „Valour Funds SPC“ einen neuen Geschäftsbereich ein und präsentiert ihren ersten Hedgefonds, den „Smart Crypto Fund SP“, der auf der proprietären KI-Strategie von Neuronomics…

Indeterminate GlobeNewswire
Valour, la filiale de DeFi Technologies, lance Valour Funds SPC, une nouvelle branche d’activité, et présente son premier fonds spéculatif, le Smart Crypto Fund SP, alimenté par la stratégie d’IA propriétaire de Neuronomics
Sep. 21, 2026

Valour, la filiale de DeFi Technologies, lance Valour Funds SPC, une nouvelle branche d’activité, et présente son premier fonds spéculatif, le Smart Crypto Fund SP, alimenté par la stratégie d’IA propriétaire de Neuronomics

Indeterminate GlobeNewswire
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
Sep. 21, 2026

Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire
Host Digital Inc. Announces Closing of Common Stock Offering
Sep. 21, 2026

Host Digital Inc. Announces Closing of Common Stock Offering

Indeterminate GlobeNewswire
H2O America Receives Regulatory Approval for Texas Subsidiary’s Cibolo Valley Acquisition
Sep. 21, 2026

H2O America Receives Regulatory Approval for Texas Subsidiary’s Cibolo Valley Acquisition

Indeterminate GlobeNewswire
Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update
Sep. 21, 2026

Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
LI BANG INTERNATIONAL CORPORATION INC. Announces Adjournment of Extraordinary General Meeting
Sep. 21, 2026

LI BANG INTERNATIONAL CORPORATION INC. Announces Adjournment of Extraordinary General Meeting

Indeterminate GlobeNewswire
Kimberly A. Boynton Named to NBT Board of Directors
Sep. 21, 2026

Kimberly A. Boynton Named to NBT Board of Directors

Indeterminate GlobeNewswire
CVRx Appoints John Landry as Chief Financial Officer
Sep. 21, 2026

CVRx Appoints John Landry as Chief Financial Officer

Indeterminate GlobeNewswire
Oportun Appoints Bernardo Martinez as Chief Retail and Sales Officer and Garrett Hope as Chief Product Officer
Sep. 21, 2026

Oportun Appoints Bernardo Martinez as Chief Retail and Sales Officer and Garrett Hope as Chief Product Officer

Indeterminate GlobeNewswire
Abivax Presents Business Updates and First Half 2026 Financial Results 
Sep. 21, 2026

Abivax Presents Business Updates and First Half 2026 Financial Results 

Indeterminate GlobeNewswire
Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Sep. 21, 2026

Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026

Indeterminate GlobeNewswire
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Sep. 21, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CSX Corp. Announces Date for Third Quarter Earnings Release and Conference Call
Sep. 21, 2026

CSX Corp. Announces Date for Third Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire
Forward Industries’ SOL Holdings Rise to Approximately 8.16 Million SOL
Sep. 21, 2026

Forward Industries’ SOL Holdings Rise to Approximately 8.16 Million SOL

Indeterminate GlobeNewswire
Vicor Corporation Raises Q3 2026 Revenue Guidance
Sep. 21, 2026

Vicor Corporation Raises Q3 2026 Revenue Guidance

Indeterminate GlobeNewswire
CAR DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR
Sep. 21, 2026

CAR DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 29 Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR

Indeterminate GlobeNewswire
TestoPrime 2026: Announces Updated TestoPrime Gold Supplement Natural Testosterone Booster For Men for Men’s Over 40.
Sep. 21, 2026

TestoPrime 2026: Announces Updated TestoPrime Gold Supplement Natural Testosterone Booster For Men for Men’s Over 40.

Indeterminate GlobeNewswire
Deadline Alert: Taboola.com Ltd. (TBLA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Sep. 21, 2026

Deadline Alert: Taboola.com Ltd. (TBLA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.